Adjuvant Bevacizumab Fails to Help in High-Risk Breast Cancer

The addition of bevacizumab to adjuvant chemotherapy regimens does not improve survival in women with high-risk breast cancer.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news